DB14642ApprovedSmall molecule
Lypressin: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Vasopressin V1a receptor, Vasopressin V2 receptor, and Vasopressin V1b receptor
- Formula / weight
- C46H65N13O12S2 · 1056.23 g/mol (avg)
- Also known as
- 8-L-lysinevasopressin · Lysine vasopressin · Vasopressin pig · Vasopressin, 8-L-lysine
Resolves to
Clinical / RWD
Structure
InChIKey
BJFIDCADFRDPIO-DZCXQCEKSA-NSMILES[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=OTransporters
What you can answer from here — as of February 21, 2021
3Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
1TransporterSubstrate / inhibitor direction, not just membershipListed above
Which drugs share a target with Lypressin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account